Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.46 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | RELA | Q04206 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5452276 | 0.98 | CA2 (0.50) | CA2FAAHRELA | |
| SCHEMBL27856585 | 0.98 | CA2 (0.50) | CA2FAAHRELA | |
| Ammonia Solution, Strong SCHEMBL28188858 | 0.98 | CA2 (0.45) | CA2FAAHRELACA1 | |
| SCHEMBL5448578 | 0.98 | CA2 (0.50) | CA2FAAHRELA | |
| SCHEMBL3045542 | 0.98 | CA2 (0.50) | CA2FAAHRELA | |
| SCHEMBL9154551 | 0.98 | CA2 (0.50) | CA2FAAHRELA | |
| SCHEMBL28333170 | 0.98 | CA2 (0.50) | CA2FAAHRELA | |
| SCHEMBL5446492 | 0.98 | CA2 (0.50) | CA2FAAHRELA | |
| SCHEMBL5444476 | 0.98 | CA2 (0.50) | CA2FAAHRELA | |
| SCHEMBL5446575 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 504 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115819414-A | N-acyl-containing aryl hydrazone derivatives, and preparation method and application thereof | 沈阳药科大学 | 2023-03-21 | — | — | CN | claimed |
| CN-115537851-A | Electrochemical synthesis method of fully-substituted sulfonylated pyrazole compound | 上海应用技术大学 | 2022-12-30 | — | — | CN | claimed |
| CN-112920123-B | 3-aryl-6-aralkyl-1, 4,5, 6-tetrahydropyrazines compound and preparation method and application thereof | 江苏冠瑜生物科技有限公司 | 2022-09-16 | — | — | CN | claimed |
| CN-109651310-B | N-furanone aryl sulfonyl hydrazide derivative and preparation method and application thereof | 华南师范大学 | 2022-07-22 | — | — | CN | claimed |
| EP-4025551-A1 | NEW METHOD FOR SYNTHESIS OF 2-METHYL-2-HYDROXYHEPTANE AND 2-METHYL 2-ALKOXYHEPTANES | P2 Science, Inc. (US) | 2022-07-13 | — | — | EP | claimed |
| CN-114539107-A | Aromatic sulfonyl modified difluoromethyl reaction building block and synthesis method thereof | 平顶山学院 | 2022-05-27 | — | — | CN | claimed |
| CN-112410807-B | Preparation method of tetra-substituted sulfonated vinyl ether under electrocatalysis | 青岛科技大学 | 2022-05-20 | — | — | CN | claimed |
| US-11332426-B2 | Method of preparing trisubstituted ethylene compounds | TRUSTEES OF BOSTON COLLEGE (US) | 2022-05-17 | — | — | US | claimed |
| CN-112811974-B | Novel aryl trifluoroethylene synthesized by arylation reagent and preparation method thereof | 中昊晨光化工研究院有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-111689883-B | Synthetic method of diaryl sulfone compound | 上海应用技术大学 | 2022-02-11 | — | — | CN | claimed |
| US-5721103-A | SKIN DISORDERS; VISION DEFECTS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1998-02-24 | — | — | US | claimed |
| EP-0800503-A1 | NOVEL TRIENOIC RETINOID COMPOUNDS AND METHODS | LIGAND PHARMACEUTICALS, INC. (US) | 1997-10-15 | — | — | EP | claimed |
| WO-1996020913-A1 | NOVEL TRIENOIC RETINOID COMPOUNDS AND METHODS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1996-07-11 | — | — | WO | claimed |
| US-5300536-A | Vinyl compound capable of free radical polymerization | TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) | 1994-04-05 | — | — | US | claimed |
| EP-0536426-A1 | NOVEL CYCLOHEXENE DERIVATIVE AND PRODUCTION THEREOF | JAPAN TOBACCO INC. (JP) | 1993-04-14 | — | — | EP | claimed |
| EP-0369212-B1 | DERIVATIVES OF (HETERO)ARYLOXYNAPHTHALENE, PROCESS, AND (HETERO)ARYLOXYNAPHTHYL AMINES, AND THEIR USE AS HERBICIDES | BAYER AG (DE) | 1993-02-17 | — | — | EP | claimed |
| EP-0369212-A1 | Derivatives of (hetero)aryloxynaphthalene, process, and (hetero)aryloxynaphthyl amines, and their use as herbicides | BAYER AG (DE) | 1990-05-23 | — | — | EP | claimed |
| EP-0347679-A1 | 1,7-Dioxynaphthalene derivatives | BAYER AG (DE) | 1989-12-27 | — | — | EP | claimed |
| US-4510270-A | INCORPORATING A POLYPHOSPHORIC ACID IN A POLYMER; SCREWS | OKURA KOGYO KABUSHIKI KAISHA (JP) | 1985-04-09 | — | — | US | claimed |
| US-4116985-A | Novel method for preparing cholesta-5,7-diene 3β,25-diol and derivatives thereof | THE UPJOHN COMPANY (US) | 1978-09-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11332426-B2 | Method of preparing trisubstituted ethylene compounds | EMC1, EMC2, ESR1 | CA2 2927/4885FAAH 1217/4885RELA 2017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.